reuters merck - Search News

SpringWorks, Merck

Hosted on MSN · 21h

Germany's Merck in advanced talks to acquire US biotech firm SpringWorks

(This Feb. 10 story has been refiled to say 'LOEs (loss of exclusivity),' not 'LOEs (levels of evidence),' in paragraph 13) By Sabrina Valle and Patricia Weiss NEW YORK/FRANKFURT (Reuters) - Merck KGaA,

Merck In Talks to Buy Cancer Drugmaker Springworks

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout

Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential acquisition, though details of its offer have yet to be revealed.

13d

Merck to stop lung condition drug study early due to strong efficacy data

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results